215 related articles for article (PubMed ID: 19465452)
1. Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report.
Ledinek AH; Jazbec SS; Drinovec I; Rot U
Mult Scler; 2009 Jul; 15(7):885-6. PubMed ID: 19465452
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: a case report.
Caravita S; Secchi MB; Wu SC; Pierini S; Paggi A
Cardiology; 2011; 120(4):187-9. PubMed ID: 22269997
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
[TBL] [Abstract][Full Text] [Related]
4. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
[TBL] [Abstract][Full Text] [Related]
5. Synergistic therapeutic effects of 2-methoxyestradiol with either sildenafil or bosentan on amelioration of monocrotaline-induced pulmonary hypertension and vascular remodeling.
Tofovic SP; Jones TJ; Bilan VP; Jackson EK; Petrusevska G
J Cardiovasc Pharmacol; 2010 Nov; 56(5):475-83. PubMed ID: 20881615
[TBL] [Abstract][Full Text] [Related]
6. Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis.
Gibbons E; Promislow S; Davies RA; Chandy G; Stewart DJ; Vladamir CD; Pugliese C; Dunne R; Mielniczuk LM
Can Respir J; 2015; 22(5):263-5. PubMed ID: 26083539
[TBL] [Abstract][Full Text] [Related]
7. Arterial hypertension induced by interferon beta 1b in a patient with multiple sclerosis.
Modrego PJ; Gazulla J
Mult Scler; 2012 Nov; 18(11):1655-6. PubMed ID: 22419671
[No Abstract] [Full Text] [Related]
8. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study.
Frantz RP; Durst L; Burger CD; Oudiz RJ; Bourge RC; Franco V; Waxman AB; McDevitt S; Walker S
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):550-7. PubMed ID: 24742768
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic treatment for pulmonary arterial hypertension.
Sastry BK
Curr Opin Cardiol; 2006 Nov; 21(6):561-8. PubMed ID: 17053404
[TBL] [Abstract][Full Text] [Related]
10. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
Benza RL; Seeger W; McLaughlin VV; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubin LJ
J Heart Lung Transplant; 2011 Dec; 30(12):1327-33. PubMed ID: 22055098
[TBL] [Abstract][Full Text] [Related]
13. Consecutive use of sildenafil and bosentan for the treatment of pulmonary arterial hypertension associated with collagen vascular disease: sildenafil as reliever and bosentan as controller.
Kamata Y; Iwamoto M; Minota S
Lupus; 2007; 16(11):901-3. PubMed ID: 17971364
[TBL] [Abstract][Full Text] [Related]
14. Management of pulmonary arterial hypertension with a focus on combination therapies.
Benza RL; Park MH; Keogh A; Girgis RE
J Heart Lung Transplant; 2007 May; 26(5):437-46. PubMed ID: 17449411
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
16. Relation of bosentan, iloprost, and sildenafil with growth factor levels in monocrotaline-induced pulmonary hypertension.
Yigitaslan S; Sirmagul B
Clin Exp Hypertens; 2012; 34(3):222-9. PubMed ID: 22468718
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].
Xiong CM; He JG; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):370-4. PubMed ID: 21418907
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963
[TBL] [Abstract][Full Text] [Related]
19. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
20. Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan.
Kiakouama L; Cottin V; Etienne-Mastroïanni B; Khouatra C; Humbert M; Cordier JF
Eur Respir J; 2010 Jul; 36(1):202-4. PubMed ID: 20595165
[No Abstract] [Full Text] [Related]
[Next] [New Search]